The analysis, published in the Journal of the American College of Cardiology, found that post-TAVR STEMI might be rare, but it can lead to substantial complications. 

The American Heart Association has emphasized that the benefits of being vaccinated still "enormously outweigh" the risks. 

The study's authors looked at data from more than 2,000 patients who had their first MI at the age of 50 or younger.

The new analysis included imaging data from nearly 3,500 adults with no prior history of CVD.

In total, the recall affects 31,798 venous stent systems distributed to customers from September 2018 to April 2021.

Researchers completed an updated analysis of the SPRINT study, sharing their results in the New England Journal of Medicine.

According to the real-world analysis, treatment with TriClip was associated with no major adverse events and a procedural success rate of 100%. 

The technique can pinpoint minor changes indicating the development of pre-aneurysmal lesions, researchers explained in Cell Reports Medicine.

A government watchdog said the miss was solely attributed to the radiologist, with “no contributing systemic or other issues.”